Background: Portal venous occlusion represents a disorder with considerable clinical relevance. The underlying causes of portal vein thrombosis (PVT) are frequently multifactorial and include malignancies, progressive chronic liver diseases, processes localized to the epigastrium and hepatobiliary system, and acquired as well as inherited thrombophilia. The three main categorical groups are malignant thrombosis, cirrhotic PVT, and non-malignant, non-cirrhotic PVT. Methods: Review of the literature. Results: The site, the extent, its chronicity, and the course of thromboses characterize a relatively heterogeneous clinical presentation and the ensuing complications in affected patients. While the occlusion of the extrahepatic portal and splenic vein likely provokes mainly complications related to portal hypertension, mesenteric venous obstruction shows a high rate of complications and mortality due to intestinal infarction. Especially in patients with liver cirrhosis, special care is warranted with regard to PVTs due to their pathogenetic role and influence on patient survival. Conclusion: This article aims to summarize the current opinion on etiologies, risk factors, and complications of this heterogeneous condition in adults.

Keywords:
Portal vein thrombosis, Malignancy, Cirrhosis, Myeloproliferative neoplasm, Thrombophilia
1.
Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE: Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol 2010;8:200-205.
2.
Pieri G, Theocharidou E, Burroughs AK: Liver in haematological disorders. Best Pract Res Clin Gastroenterol 2013;27:513-530.
3.
Riva N, Donadini MP, Dentali F, Squizzato A, Ageno W: Clinical approach to splanchnic vein thrombosis: risk factors and treatment. Thromb Res 2012;130(suppl 1):S1-3.
4.
Plessier A, Rautou PE, Valla DC: Management of hepatic vascular diseases. J Hepatol 2012;56(suppl 1):S25-38.
5.
Acosta S, Alhadad A, Svensson P, Ekberg O: Epidemiology, risk and prognostic factors in mesenteric venous thrombosis. Br J Surg 2008;95:1245-1251.
6.
Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH: Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006;12:2115-2119.
7.
Almdal TP, Sorensen TI: Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology 1991;13:650-655.
8.
Ageno W, Squizzato A, Togna A, Magistrali F, Mangini M, Fugazzola C, Dentali F: Incidental diagnosis of a deep vein thrombosis in consecutive patients undergoing a computed tomography scan of the abdomen: a retrospective cohort study. J Thromb Haemost 2012;10:158-160.
9.
Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW: Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood 2012;120:4921-4928.
10.
Webster GJ, Burroughs AK, Riordan SM: Review article: portal vein thrombosis - new insights into aetiology and management. Aliment Pharmacol Ther 2005;21:1-9.
11.
Ponziani FR, Zocco MA, Garcovich M, D'Aversa F, Roccarina D, Gasbarrini A: What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective. World J Gastroenterol 2012;18:5014-5020.
12.
Janssen HL, Wijnhoud A, Haagsma EB, et al: Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001;49:720-724.
13.
Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK: Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther 2010;31:366-374.
14.
Okuda K, Ohnishi K, Kimura K, et al: Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985;89:279-286.
15.
Francoz C, Belghiti J, Vilgrain V, et al: Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005;54:691-697.
16.
Primignani M: Portal vein thrombosis, revisited. Dig Liver Dis 2010;42:163-170.
17.
Francoz C, Valla D, Durand F: Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol 2012;57:203-212.
18.
Kinjo N, Kawanaka H, Akahoshi T, et al: Portal vein thrombosis in liver cirrhosis. World J Hepatol 2014;6:64-71.
19.
Zocco MA, Di Stasio E, De Cristofaro R, et al: Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009;51:682-689.
20.
Amitrano L, Guardascione MA, Ames PR: Coagulation abnormalities in cirrhotic patients with portal vein thrombosis. Clin Lab 2007;53:583-589.
21.
Kinjo N, Kawanaka H, Akahoshi T, et al: Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg 2010;97:910-916.
22.
Bosch J, Garcia-Pagan JC: Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000;32:141-156.
23.
Hennenberg M, Trebicka J, Sauerbruch T, Heller J: Mechanisms of extrahepatic vasodilation in portal hypertension. Gut 2008;57:1300-1314.
24.
van't Riet M, Burger JW, van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ: Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg 2000;87:1229-1233.
25.
Amitrano L, Brancaccio V, Guardascione MA, et al: Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000;31:345-348.
26.
Monroe DM, Hoffman M: The coagulation cascade in cirrhosis. Clin Liver Dis 2009;13:1-9.
27.
Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, Burroughs AK: Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost 2010;8:1994-2000.
28.
Tripodi A, Mannucci PM: Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol 2007;46:727-733.
29.
Senzolo M, Cholongitas EC, Patch D, Burroughs AK: Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2005;2:182-190.
30.
Violi F, Ferro D, Basili S, et al: Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost 1997;77:44-47.
31.
Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC: Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost 2011;9:1713-1723.
32.
Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al: Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010;51:210-218.
33.
Turon F, Cervantes F, Colomer D, Gaiges A, Hernández-Gea V, Garcia-Pagán JC: Role of calreticulin mutations in the etiological diagnosis of splanchnic vein thrombosis. J Hepatol 2014; DOI: 10.1016/j.jhep.2014.08.032.
34.
Cohen J, Edelman RR, Chopra S: Portal vein thrombosis: a review. Am J Med 1992;92:173-182.
35.
Condat B, Pessione F, Hillaire S, et al: Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001;120:490-497.
36.
Lee SS, Ha HK, Park SH, Choi EK, Kim AY, Kim JC, Han DJ: Usefulness of computed tomography in differentiating transmural infarction from nontransmural ischemia of the small intestine in patients with acute mesenteric venous thrombosis. J Comput Assist Tomogr 2008;32:730-737.
37.
DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study of Liver Diseases: Vascular disorders of the liver. Hepatology 2009;49:1729-1764.
38.
Brunaud L, Antunes L, Collinet-Adler S, Marchal F, Ayav A, Bresler L, Boissel P: Acute mesenteric venous thrombosis: case for nonoperative management. J Vasc Surg 2001;34:673-679.
39.
Condat B, Valla D: Nonmalignant portal vein thrombosis in adults. Nat Clin Pract Gastroenterol Hepatol 2006;3:505-515.
40.
de Franchis R: Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-176.
41.
Valla DC, Condat B: Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000;32:865-871.
42.
Wiesner W, Khurana B, Ji H, Ros PR: CT of acute bowel ischemia. Radiology 2003;226:635-650.
43.
Garcia-Pagan JC, Hernandez-Guerra M, Bosch J: Extrahepatic portal vein thrombosis. Semin Liver Dis 2008;28:282-292.
44.
Amitrano L, Guardascione MA, Scaglione M, et al: Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007;102:2464-2470.
45.
Hoekstra J, Janssen HL: Vascular liver disorders (II): portal vein thrombosis. Neth J Med 2009;67:46-53.
46.
Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H: Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol 2007;7:34.
47.
Condat B, Vilgrain V, Asselah T, et al: Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology 2003;37:1302-1308.
48.
Dhiman RK, Behera A, Chawla YK, Dilawari JB, Suri S: Portal hypertensive biliopathy. Gut 2007;56:1001-1008.
49.
Llop E, de Juan C, Seijo S, Garcia-Criado A, Abraldes JG, Bosch J, Garcia-Pagan JC: Portal cholangiopathy: radiological classification and natural history. Gut 2011;60:853-860.
50.
Wanless IR, Liu JJ, Butany J: Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995;21:1232-1237.
51.
Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G: Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995;21:1238-1247.
52.
Englesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM: Portal vein thrombosis and liver transplant survival benefit. Liver Transpl 2010;16:999-1005.
53.
Doenecke A, Tsui TY, Zuelke C, Scherer MN, Schnitzbauer AA, Schlitt HJ, Obed A: Pre-existent portal vein thrombosis in liver transplantation: influence of pre-operative disease severity. Clin Transplant 2010;24:48-55.
© 2015 S. Karger GmbH, Freiburg
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.